Monday, April 21, 2008

AstraZeneca - Seroquel: The DelBello Affair contd.


The University of Cincinnati will increase scrutiny on a psychiatry professor for not reporting all of the hundreds of thousands of dollars in corporate research money she received from a pharmaceutical giant during the last decade.

Melissa DelBello now has to review all of of her interactions with companies with her department chairman, UC vice president of research Sandra Degen said Friday.

DelBello's teaching and research haven't been restricted, but the fact that she didn't tell the university about some of her outside income has been detailed in her personnel file.

"It's to protect her," Degen said. "Basically, we were documenting that there were some discrepancies in what was reported."

No comments: